Indaptus Therapeutics (INDP) Return on Equity [ROE] (2021 - 2026)
Indaptus Therapeutics' Return on Equity [ROE] was -234.11% in Q2 2026, up 2667.76 percentage points from -2901.87% a year earlier and up 557.83 percentage points from the prior quarter.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Indaptus Therapeutics came in at -558.97%, down 367.15 percentage points from FY2024.
- Return on Equity [ROE] has now declined for four consecutive years, with a four-year change of -515.62 percentage points (FY2021 to FY2025).
- In earlier years, Return on Equity [ROE] was -191.82% in FY2024 (-102.58 pp), -89.24% in FY2023 (-39.97 pp), -49.27% in FY2022 (-5.92 pp) and -43.35% in FY2021.
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q2 2024.
- Compared with a year earlier, Return on Equity [ROE] was higher in 1 of the last eight quarters, with an average year-over-year change of -255.33 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2026 (a gain of 2667.76 percentage points); the worst was Q2 2025 (a drop of 2689.59 percentage points).
- Per Business Quant data, INDP's Return on Equity [ROE] in the three quarters before Q2 2026 was -791.94% (Q1 2026), -511.35% (Q4 2025) and -1080.99% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Indaptus Therapeutics | 185.93 Mn | 158.54 Mn | - | -234.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -234.11% |
| Mar 31, 2026 | -791.94% |
| Dec 31, 2025 | -511.35% |
| Sep 30, 2025 | -1,078.23% |
| Jun 30, 2025 | -2,881.71% |
| Mar 31, 2025 | -468.16% |
| Dec 31, 2024 | -302.00% |
| Sep 30, 2024 | -244.77% |
| Jun 30, 2024 | -204.57% |
| Mar 31, 2024 | -141.38% |
| Dec 31, 2023 | -113.24% |
| Sep 30, 2023 | -88.88% |
| Jun 30, 2023 | -72.64% |
| Mar 31, 2023 | -65.59% |
| Dec 31, 2022 | -54.51% |
| Sep 30, 2022 | -47.84% |
| Jun 30, 2022 | -43.32% |
| Mar 31, 2022 | -30.25% |
| Dec 31, 2021 | -20.85% |
| Sep 30, 2021 | -28.64% |
API Access
Indaptus Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();